₹81.47 Crores | Listing at BSE, NSE | Mon, Jul 28, 2025 - Fri, Aug 8, 2025
Valiant Laboratories Limited Rights Issue comprises 1.09 Cr equity shares aggregating to ₹81.47 Cr, offered at an issue price of ₹75 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Jul 19, 2025, with the Rights Issue being offered in the entitlement ratio of 1 : 4.
The term of payment is defined as following : As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Aug 11, 2025.
The Rights Issue opens on Jul 28, 2025, and closes on Aug 8, 2025, with renunciation of Rights Entitlements permitted up to Aug 5, 2025.
The deemed date of allotment is Aug 11, 2025, following which the equity shares are expected to be credited to demat accounts on Aug 12, 2025 and listed at the NSE and the BSE on Aug 13, 2025.
MUFG Intime India Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Valiant Laboratories Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Sat, Jul 19, 2025
Entitlement Ratio
1 : 4
Open Date
Mon, Jul 28, 2025
Close Date
Fri, Aug 8, 2025
As per Terms of Payment, The Full amount of the Issue Price, being Rs . 75/- per share, will be payable on Application.
Valiant Laboratories Limited's revenue decreased by 27% and profit after tax (PAT) dropped by 789% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 |
| Revenue | 133.38 | 182.06 |
| Profit After Tax | -2.20 | 0.32 |
| Net Worth | 234.31 | 236.86 |
| Reserves and Surplus | 190.86 | 193.41 |
| Amount in ₹ Crore | ||
Founded in 1980, Valiant Laboratories Limited, an Indian API manufacturer specializing in Paracetamol. Part of the Aarti Group, it has a manufacturing unit in Palghar, Maharashtra, with significant capacity.
The core business of the company is the manufacturing of Active Pharmaceutical Ingredients (APIs), with a primary focus on Paracetamol.
They produce various grades of Paracetamol API, including those that meet Indian, British, European, and United States Pharmacopoeia standards.
Valiant Laboratories has a dedicated manufacturing unit in Palghar, Maharashtra, with a substantial annual production capacity.
The company uses a strong business model blending expertise and innovation to meet changing market needs.
The intend to utilise the gross proceeds raised through the Issue (the “Issue Proceeds”) after deducting the Issue-related expenses (“Net Proceeds”) for the below-mentioned Objects (collectively, referred to as the “Objects”):
[Dilip Davda] VLL is engaged in manufacturing of bulk drug/ API etc. It posted a setback for FY25 with lower top line coupled with losses. Considering losses for FY25, the issue is priced negatively. The counter is well operated by operators and kept above the RI price. Well-informed/cash surplus investors may park moderate funds for long term. Read detail review...
Valiant Laboratories Limited Rights Issue 2025 got subscribed by 0.63 times by the end of the bidding period with total bid quantity received by BSE and NSE of 68,81,262 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | NSE Bid Quantity | Total Bid Quantity | Subscription Times |
|---|---|---|---|---|
Aug 08 2025 17:00:00 | 60,12,562 | 8,68,700 | 68,81,262 | 0.63x |
Valiant Laboratories Limited
104, Udyog Kshetra,
Mulund-Goregaon Link
Road, Mulund (W)
Mumbai, 400080
The Valiant Laboratories Limited Rights Issue 2025 opens on Mon, Jul 28, 2025, and closes on Fri, Aug 8, 2025.
Valiant Laboratories Limited Rights Issue 2025 Schedule
| Last Date for credit of Rights Entitlements | Mon, Jul 21, 2025 |
| Last Date for renunciation of Rights Entitlements | Tue, Aug 5, 2025 |
| Issue Opening Date | Mon, Jul 28, 2025 |
| Issue Closing Date | Fri, Aug 8, 2025 |
| Date of Allotment (on or about) | Mon, Aug 11, 2025 |
| Date of Credit (on or about) | Tue, Aug 12, 2025 |
| Date of Listing (on or about) | Wed, Aug 13, 2025 |
You can apply for Valiant Laboratories Limited Rights Issue 2025 in two ways:
Steps to apply for Valiant Laboratories Limited Rights Issue 2025 using Net Banking (ASBA)
Steps to apply for Valiant Laboratories Limited Rights Issue 2025 using Registrar's website (R-WAP)
